We hope everyone is well and coping with the challenges of the COVID-19 pandemic. With information changing on a daily basis, we are reaching out to the NMOSD community to aid in your navigation of the many questions at hand. While the Foundation does not provide clinical care policies or recommendations, we hope these 10 frequently asked questions assist all NMOSD patients to make informed decisions with their doctors. Click here to read our NMOSD & COVID-19 FAQs.
More Videos from Online Breakout Sessions
Online Breakout Session: Approved Therapeutics
Industry Council Members Horizon (formerly Viela-Bio), Genentech, and Alexion discuss their FDA-approved treatments for NMOSD.
Online Breakout Sessions, Therapeutic Breakout Session
Online Breakout Session: Access to Care
NMOSD Access to Care Hosted by Jill Pollander, Director of Patient Services at NORD; Stephanie Marshall, Director of Patient Advocacy at TAF
Online Breakout Sessions
Online Breakout Session: COVID-19 Vaccines and Variants (Jan 29)
NMOSD & COVID-19 News on Facebook Live, hosted by GJCF Chief Medical Advisor Michael Yeaman, Harbor-UCLA Medical Center.
Online Breakout Sessions
Online Breakout Session: NMOSD & COVID-19 Update (Dec 4)
NMOSD & COVID-19 News hosted by GJCF Chief Medical Advisor Michael Yeaman, Chief of Molecular Medicine, Harbor-UCLA Medical Center.
Online Breakout Sessions